Overview

Intrathecal Dexmedetomidine vs Midazolame

Status:
COMPLETED
Trial end date:
2022-03-10
Target enrollment:
Participant gender:
Summary
Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries
Phase:
PHASE4
Details
Lead Sponsor:
National Cancer Institute, Egypt
Treatments:
Bupivacaine
Dexmedetomidine
Midazolam